http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2564147-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e0bf0928b608797b70bbc2b91c7e52e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B53-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-62
filingDate 2006-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3262710f2b97da4a04c587b836f811e7
publicationDate 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2564147-T3
titleOfInvention Procedure for the preparation of optically active aminoalkylphenols
abstract Process for the preparation of optically active compounds of formulas IS and/or IR**Formula** in which n represents 0, 1 or 2 and m represents 0, 1 or 2, comprising the following steps: (i) reacting a mixture of enantiomers of formula II**Formula** in which P represents a protecting group, which is selected from tert-butyl and an optionally substituted benzyl group on the phenyl ring, with an acylating agent in the presence of a hydrolase , obtaining a mixture in which one enantiomer of compound (II) is essentially in the acylated form and the other enantiomer of compound (II) is essentially in the unacylated form; (ii) separating the unacylated enantiomer of compound (II) from the mixture obtained in step (i); (iii) deprotecting the unacylated enantiomer of compound (II) obtained in step (ii) to give amine (I-S) or (IR); and (iv) if desired, hydrolyzing the essentially acylated enantiomer of compound (II) obtained in step (i) to give the corresponding non-acylated enantiomer of amine (II) and further deprotecting to give amine (IR) or ( SI); obtaining the compound of formula (II) (a) by protecting a compound of formula (III)**Formula** in the OH group with obtaining compound (IV)**Formula** and (b) by subjecting the compound (IV) to a reductive amination, obtaining the compound of formula (II).
priorityDate 2005-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451829787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414500521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448677000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414537560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410554345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID170206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23696331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67253988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419904080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67254220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594792
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413416973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67255125

Total number of triples: 47.